LINC00479: A Potential Drug Target and Biomarker for Various Diseases

Target Name: LINC00479

NCBI ID: G150135

Other Name(s): C21orf129 | PRED76 | Long intergenic non-protein coding RNA 479 | long intergenic non-protein coding RNA 479

LINC00479: A Potential Drug Target and Biomarker for Various Diseases

LINC00479 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and recent studies have provided valuable insights into its role in various biological processes.

LINC00479 is a long non-coding RNA molecule that has a length of approximately 290 nucleotides. It is expressed in various tissues and cells throughout the body and has been shown to play a role in various biological processes, including cell growth, differentiation, and inflammation . One of its unique features is its ability to self-assemble into a stable complex, known as a RNA-protein scaffold, which has been shown to play a role in regulating gene expression and promoting cellular processes.

LINC00479 has also been shown to be involved in the regulation of cellular signaling pathways. It has been shown to interact with various proteins, including the oncogene PDGF-BB, and has been shown to play a role in the regulation of PDGF signaling in cancer cells . Additionally, LINC00479 has been shown to interact with the transcription factor NF-kappa-B and has been shown to play a role in the regulation of NF-kappa-B signaling in cancer cells.

LINC00479 has also been shown to be involved in the regulation of cellular apoptosis, which is the process by which cells die naturally in response to various stimuli, including cancer cells. It has been shown to play a role in the regulation of apoptosis in cancer cells and has been shown to have neuroprotective effects in cancer models.

In addition to its role in cellular signaling pathways, LINC00479 has also been shown to be involved in the regulation of gene expression and has been used as a potential drug target in various diseases. Its unique structure and expression patterns have made it an attractive target for researchers to study and develop new treatments for various diseases.

One of the challenges in studying LINC00479 is its relatively short length, which makes it difficult to study its function in depth. Additionally, the lack of information about its exact mechanism of action makes it difficult to predict its potential benefits and risks as a drug. Despite these challenges, recent studies have provided valuable insights into its role in various biological processes and have identified its potential as a drug target in cancer.

In conclusion, LINC00479 is a non-coding RNA molecule that has unique structure and expression patterns and has been shown to play a role in various biological processes, including cell growth, differentiation, and inflammation. Its potential as a drug target and biomarker makes it an attractive target for researchers to study and develop new treatments for various diseases. Further studies are needed to fully understand its function and potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 479

More Common Targets